Patents by Inventor Daniel Bucks

Daniel Bucks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250107922
    Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.
    Type: Application
    Filed: July 23, 2024
    Publication date: April 3, 2025
    Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks
  • Patent number: 12070411
    Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: August 27, 2024
    Assignee: Zeltiq Aesthetics, Inc.
    Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks
  • Patent number: 11737994
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: August 29, 2023
    Assignee: PROPELLA THERAPEUTICS INC.
    Inventors: Philip J. Birbara, Daniel Bucks
  • Publication number: 20220168247
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: September 17, 2021
    Publication date: June 2, 2022
    Inventors: Philip J. BIRBARA, Daniel BUCKS
  • Patent number: 11123315
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: September 21, 2021
    Assignee: Propella Therapeutics, Inc.
    Inventors: Philip J. Birbara, Daniel Bucks
  • Publication number: 20210100759
    Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: October 12, 2020
    Publication date: April 8, 2021
    Inventors: Daniel BUCKS, Philip J. BIRBARA
  • Patent number: 10821088
    Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: September 10, 2014
    Date of Patent: November 3, 2020
    Assignee: PROPELLA THERAPEUTICS, INC.
    Inventors: Daniel Bucks, Philip J. Birbara
  • Publication number: 20200323800
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: January 16, 2020
    Publication date: October 15, 2020
    Inventors: Philip J. BIRBARA, Daniel Bucks
  • Publication number: 20200155215
    Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.
    Type: Application
    Filed: October 8, 2019
    Publication date: May 21, 2020
    Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks
  • Patent number: 10583100
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: March 10, 2020
    Assignee: VIZURI HEALTH SCIENCES LLC
    Inventors: Philip J. Birbara, Daniel Bucks
  • Publication number: 20190247337
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: January 9, 2019
    Publication date: August 15, 2019
    Inventors: Philip J. BIRBARA, Daniel BUCKS
  • Publication number: 20190142948
    Abstract: Capsaicinoid formulations and methods of treatment are disclosed herein which can be utilized to treat/attenuate pain in mammals. Typically, administration is via injection at a discrete site to provide pain relief for an extended period of time. The formulations are administered in a pharmaceutically acceptable vehicle. The formulations include an analgesic agent in an amount sufficient to attenuate the burning and hyperalgesic effects of capsaicinoid administration. The invention also includes a method of treating pain by administering a corticosteroid followed by administration of a capsaicinoid.
    Type: Application
    Filed: January 10, 2019
    Publication date: May 16, 2019
    Inventors: Charles A. BIRBARA, Philip J. BIRBARA, Daniel BUCKS, Mary COUGHLIN
  • Patent number: 10206892
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: February 19, 2019
    Assignee: VIZURI HEALTH SCIENCES LLC
    Inventors: Philip J. Birbara, Daniel Bucks
  • Publication number: 20190022110
    Abstract: Capsaicinoid formulations and methods of treatment are disclosed herein which can be utilized to treat/attenuate pain in mammals. Typically, administration is via injection at a discrete site to provide pain relief for an extended period of time. The formulations are administered in a pharmaceutically acceptable vehicle. The formulations include an analgesic agent in an amount sufficient to attenuate the burning and hyperalgesic effects of capsaicinoid administration. The invention also includes a method of treating pain by administering a corticosteroid followed by administration of a capsaicinoid.
    Type: Application
    Filed: July 26, 2018
    Publication date: January 24, 2019
    Inventors: Charles A. Birbara, Philip J. Birbara, Daniel Bucks, Mary Coughlin
  • Patent number: 10085956
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: October 2, 2018
    Assignee: VIZURI HEALTH SCIENCES LLC
    Inventors: Philip J. Birbara, Daniel Bucks
  • Publication number: 20180250246
    Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: May 7, 2018
    Publication date: September 6, 2018
    Inventors: Daniel BUCKS, Philip J. BIRBARA
  • Publication number: 20180214397
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: March 29, 2018
    Publication date: August 2, 2018
    Inventors: Philip J. BIRBARA, Daniel BUCKS
  • Publication number: 20180214398
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: March 29, 2018
    Publication date: August 2, 2018
    Inventors: Philip J. BIRBARA, Daniel BUCKS
  • Patent number: 9956190
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: May 1, 2018
    Assignee: VIZURI HEALTH SCIENCES LLC
    Inventors: Philip J. Birbara, Daniel Bucks
  • Publication number: 20160106690
    Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: September 10, 2014
    Publication date: April 21, 2016
    Applicant: API GENESIS, LLC
    Inventors: Daniel BUCKS, Philip J. BIRBARA